Rick Ryan

Investor

Missouri

Writes $100K – $3.5M checks · typically $1.8M

About

Rick Ryan has over 35 years of experience in business management and technology development within the life science industry, holding executive roles at both multinationals and early-stage ventures. He was VP of the Drug Discovery & Development business unit at Millipore until 2010 and previously served as President of LINCO Research and held Director-level positions at Monsanto. He currently serves as CEO of Apertus Pharmaceuticals, and holds a B.S. in Chemistry, a PhD in Biochemistry, and an executive MBA from Washington University in St. Louis.

LinkedIn ↗

Invests in

Biotech

Experience

Cultivation Capital Life SciencesGeneral Partnercurrent2013 — presentSt. Louis
The Winfield GroupPresidentcurrent2011 — presentSt. Louis MO
Apertus PharmaceuticalsExec Chairmancurrent2024 — presentSt. Louis, MO
Apertus PharmaChief Executive Officer2012 — 2024St, Louis
MilliporeVice President, Drug Discovery Business Unit2006 — 2010
Linco ResearchPresident1999 — 2006
EmbrexVice President, Global Commercial Development1996 — 1998Research Triangle Park, NC
MonsantoVarious Dir and Mgr level positions1982 — 1996

Education

Washington University in St. LouisMBA, Business Administration/Marketing1992 — 1994
University of Illinois Urbana-ChampaignPhD, Biochemistry1971 — 1976
Central CollegeBS, Chemistry1966 — 1970

Skills & more

Chemistry23Life Sciences53ELISA19Drug Discovery85PharmaceuticalsCommercialization70Molecular Biology7Lifesciences48Entrepreneurship8Biotechnology98Immunology9Protein Chemistry3

+12 more

VaccinesTechnology TransferBiomarker DiscoveryValidationBiopharmaceuticalsCross-functional Team LeadershipDrug DevelopmentGLPStrategyLeadershipPharmaceutical IndustryMedicinal Chemistry

From Rick's professional profile.